Private Placement

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

As LunR Royalties begins trading, its parent NGEx Minerals pivots to unlock the potential of its world-class copper-gold assets in South America.

$8.4M in Home4Good grants will fund 110 programs in DE, PA, and WV, offering a lifeline as housing insecurity deepens across the region.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

Bolstered by positive clinical data and top investors, Kalaris Therapeutics extends its runway to advance TH103, a next-gen treatment for neovascular AMD.

Amid surging investor confidence, Copper Road Resources has twice increased its private placement, securing nearly $1M for critical mineral exploration in Ontario.

As holiday needs surge, a $75,000 donation from a local credit union provides critical support to organizations battling hunger and homelessness in the region.

As the market for oral supplements explodes, products like Synadentix promise a healthier mouth. But does the science back the billion-dollar marketing?

With a $2.3M investment, Welland is adding 4.5 km of trails, boosting health, property values, and setting a model for national green infrastructure.

CERo Therapeutics reports early safety success and dose escalation in its Phase 1 AML trial for CER-1236, a novel cell therapy for high-risk patients.

Tebra's new $250M funding aims to level the playing field for private practices with AI tools that automate tasks and boost profitability.

Dartmouth Cancer Center gains a top designation for using GammaTile, an innovative implant that delivers immediate radiation during brain tumor surgery.

KULR Technology leverages its space-grade safety tech for AI's immense power needs, entering a key partnership backed by a unique Bitcoin treasury.

New data reveals a novel wound gel is successfully treating conditions previously deemed unhealable, offering hope against chronic wounds and antibiotic resistance.

Cubist's new C2F platform uses confidential computing to solve a core Web3 dilemma, promising private, high-speed off-chain logic with on-chain guarantees.

Nav's new pilot empowers small businesses to extend trade credit, but can its community-focused model stand out in a growing market for B2B payments?